Isis Pharmaceuticals, Inc. (ISIS) Posts Q2 Loss of 9c/Share
Get Alerts ISIS Hot Sheet
Price: $57.56 --0%
Financial Fact:
Diluted net loss (in dollars per share): 0.06
Today's EPS Names:
FSI, RELV, NEOM, More
Financial Fact:
Diluted net loss (in dollars per share): 0.06
Today's EPS Names:
FSI, RELV, NEOM, More
Join SI Premium – FREE
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q2 EPS of ($0.09), $0.12 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $38.1 million versus the consensus estimate of $26.76 million.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2 reasons why Tesla stock fell on Thursday
- P3 Health Partners Inc. (PIII) Misses Q4 EPS by 14c, reaffirms guidance
- Midday movers: RH, Estee Lauder rise; Tesla falls
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!